1
|
Amatore F, Devey S, Tabelé C, Troin L, Monestier S, Malissen N, Gaudy‐Marqueste C, Grob J, Richard M. Comparison of complementary and alternative medicine use between patients with skin cancer and inflammatory skin diseases. J Eur Acad Dermatol Venereol 2020; 34:e182-e183. [DOI: 10.1111/jdv.16142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- F. Amatore
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - S. Devey
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - C. Tabelé
- Department of Pharmacy Timone Hospital Marseille France
| | - L. Troin
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - S. Monestier
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - N. Malissen
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - C. Gaudy‐Marqueste
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - J.‐J. Grob
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| | - M.‐A. Richard
- Department of Dermatology and Oncodermatology Timone Hospital Marseille France
| |
Collapse
|
2
|
Troin L, Mallet S, Lagouanelle MC, Scannapieco F, Lignon C, Gaudy-Marqueste C, Grob JJ, Richard MA. [Five years' experience of cosmetic camouflage of disfiguring skin disorders: Patient satisfaction]. Ann Dermatol Venereol 2019; 147:4-8. [PMID: 31831215 DOI: 10.1016/j.annder.2019.09.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2016] [Revised: 04/06/2019] [Accepted: 09/03/2019] [Indexed: 10/25/2022]
Abstract
INTRODUCTION Living with disfiguring disorders can impair the emotional well-being and relationships of patients as well as their social and professional life. Since 2010, courses in medical cosmetic correction for disfiguring diseases have been conducted at the dermatology department of the Timone University Hospital in Marseille and they form part of an educational program. The aim of this study was to assess the satisfaction of patients taking part in this program. PATIENTS AND METHODS This is a retrospective study of 55 patients taking part in make-up sessions from January 2010 to December 2014 and subsequently completing a questionnaire. RESULTS The median patient age was 46 years with most being women (n=49, 89 %). They presented pigmentary disorders (54.5 %), inflammatory diseases (27.3 %) and scars (18.2 %). 75 % of patients stated that they had improved their knowledge and 82 % remarked that the technique was personalized to their needs. The technique was considered as easy by 62 % and reproducible by 87 % of patients. 55 % of patients considered that cosmetic camouflage improved their quality of life and 56 % stated that it helped them accept the gaze of others. CONCLUSION In our study skin camouflage appears easy to use and meets patient expectations.
Collapse
Affiliation(s)
- L Troin
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France.
| | - S Mallet
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - M-C Lagouanelle
- Service de santé publique hôpital de la conception, Aix-Marseille université, AP-HM, 13385 Marseille, France
| | - F Scannapieco
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - C Lignon
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - C Gaudy-Marqueste
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - J-J Grob
- Inserm CRO2, UMR 911, département de dermatologie, centre de recherche en oncologie biologique et oncopharmacologie, Aix-Marseille université, hôpital de la Timone, AP-HM, 264, rue Saint-Pierre, 13385 Marseille, France
| | - M-A Richard
- CEReSS-EA 3279, Dermatology Department, Research Center in Health Services and Quality of Life Aix-Marseille University, Universitary Hospital Timone, Assistance Publique-Hôpitaux de Marseille, AP-HM, 13385, Marseille, France
| |
Collapse
|
3
|
Guichard G, Grange F, Saiag P, Charles J, Dreno B, Guillot B, Lacour JP, Gaudy C, Monestier S, Hesse S, Khammari A, Visseaux L, Kramkimel N, Finet A, Picard A, Malissen N, Troin L, Magis Q, Richard MA, Grob JJ. Il n’y a pas de surtoxicité des BRAF-MEK inhibiteurs lorsqu’ils sont prescrits immédiatement après l’arrêt des anti-PD1. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Malissen N, Magis Q, Macagno N, Monestier S, Troin L, Mallet S, Gaudy-Marqueste C, Grob JJ, Richard MA. Réactions granulomateuses sur tatouage sous anti-BRAF + anti-MEK révélatrices de fausses progressions. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.165] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
5
|
Malissen N, Macagno N, Monestier S, Magis Q, Troin L, Mallet S, Gaudy-Marqueste C, Grob JJ, Richard MA. Localisation élective de lentigines sur des plaques de psoriasis : pigmentation kératinocytaire basale plutôt qu’effet secondaire des traitements. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Devey S, Tabelé C, Troin L, Monestier S, Gaudy C, Magis Q, Malissen N, Grob JJ, Richard MA. Traitements alternatifs en dermatologie : enquête dans un service hospitalo-universitaire. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
7
|
Magis Q, Gaudy-Marqueste C, Beliard S, Basire A, Loundou A, Malissen N, Troin L, Monestier S, Richard MA, Grob JJ. Diabète et déséquilibre glycémique sous anti-PD1. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
8
|
Gaudy-Marqueste C, Dussouil AS, Carron R, Troin L, Malissen N, Loundou A, Monestier S, Mallet S, Richard MA, Régis JM, Grob JJ. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery. Eur J Cancer 2017; 84:44-54. [PMID: 28783540 DOI: 10.1016/j.ejca.2017.07.017] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2017] [Revised: 06/16/2017] [Accepted: 07/11/2017] [Indexed: 01/04/2023]
Abstract
BACKGROUND Targeted therapy (TT) and immunotherapies (ITs) have dramatically improved survival in metastatic melanoma (MM). However, their efficacy on brain metastasis (BM) remains limited and poorly documented. PATIENTS AND METHODS Retrospective cohort of consecutive MM patients (pts) with BMs, all systematically upfront treated by Gamma-Knife (GK) at first BM and retreated in case of new BMs, from 2010 to 2015 at the time when ipilimumab BRAF ± MEK inhibitors and anti-PD1 were introduced in practice. Survival after 1st GK (OSGK1) according to prognostic factors and treatment. RESULTS Among 179 consecutive pts treated by GK, 109 received IT and/or TT after the 1st GK. Median OSGK1 was 10.95 months and 1- and 2-year survival rates were 49.5% and 27.4%, respectively, versus a median overall survival (OS) of 2.29 months (p < .001) in those who did not receive IT or TT. In pts who initially had a single BM, median OS and 1- and 2-year survival rates were 14.46 months, 66.7% and 43.4%, respectively; in pts with 2-3 BMs: 8.85 months, 46.4% and 31%, respectively; in pts with >3 BMs: 7.25 months, 37.2% and 11.9%, respectively. Multivariate analysis for OSGK1 confirmed that IT and TT were significantly and highly protective. Best OSGK1 was observed in BRAF-wild-type pts receiving anti-PD1 or in BRAF-mutated pts receiving BRAF-inhibitors and anti-PD1 (12.26 and 14.82 months, respectively). CONCLUSION In real-life MM pts with BMs, a strategy aiming at controlling BM with GK together with TT and/or TT seems to achieve unprecedented survival rates.
Collapse
Affiliation(s)
- C Gaudy-Marqueste
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - A S Dussouil
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - R Carron
- Department of Stereotaxic and Functional Neurosurgery, Gamma-knife Unit, Inserm U751, Aix-Marseille University, APHM, Marseille, France
| | - L Troin
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - N Malissen
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - A Loundou
- Public Health Department, Aix-Marseille University, APHM, Marseille, France
| | - S Monestier
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - S Mallet
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - M A Richard
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France
| | - J M Régis
- Department of Stereotaxic and Functional Neurosurgery, Gamma-knife Unit, Inserm U751, Aix-Marseille University, APHM, Marseille, France
| | - J J Grob
- Dermatology and Skin Cancers Department, UMR911 CRO2, Aix-Marseille University, APHM, Marseille, France.
| |
Collapse
|
9
|
Malissen N, Troin L, Macagno N, Abed S, Huynh C, Gaudy C, Richard MA, Grob JJ. Dermatomyosite retardée et fatale sous anti-PD1 malgré une réponse complète : une nouvelle complication des anti-PD1. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.575] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
10
|
Troin L, Richard MA, Gaudy-Marqueste C, Scannapieco F, Lignon C, Peyla L, Lagouanelle MC, Harlé JR, Grob JJ, Granel B, Mallet S. Évaluation de la qualité de vie de patients atteints de sclérodermie systémique avant/après programme d’ETP avec ateliers de maquillage médical. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.650] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Troin L, Brajon D, Combes E, Horreau C, Dales JP, Koeppel MC, Berbis P. [Plaque-like leiomyomas on a chemical burn: First case report]. Ann Dermatol Venereol 2015; 142:430-3. [PMID: 25888459 DOI: 10.1016/j.annder.2015.02.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2014] [Revised: 01/18/2015] [Accepted: 02/24/2015] [Indexed: 11/28/2022]
Abstract
BACKGROUND Cutaneous leiomyomas are uncommon benign smooth muscle neoplasms of skin of unknown pathogenesis. We report a sporadic case of multiple cutaneous leiomyomas at the site of a chemical burn. OBSERVATION A 47-year-old male presented with multiple grouped red nodules on the right calf painful to cold and to touch. The lesions were located on the site of a chemical wound that had occurred 5 years earlier. Histopathological examination revealed a proliferation of smooth muscle fibres, leading to diagnosis of leiomyoma. DISCUSSION To our knowledge, the literature contains no previous reports of sporadic multiple cutaneous leiomyomas occurring at a chemical burn site. While a chance association cannot be ruled out, there is also the possibility of a physiopathological mechanism similar to that of vascular tumours following exposure to 4-hydrazinobenzoic acid. This compound, a hydrazine derivative of the fungus Agaricus bisporus, can cause smooth-muscle tumours in the aorta and large vessels with morphological characteristics similar to those seen in vascular leiomyomas.
Collapse
Affiliation(s)
- L Troin
- Service de dermatologie, hôpital Nord, chemin des Bourrely, 13015 Marseille, France.
| | - D Brajon
- Service de dermatologie, hôpital Nord, chemin des Bourrely, 13015 Marseille, France
| | - E Combes
- Service de dermatologie, hôpital Nord, chemin des Bourrely, 13015 Marseille, France
| | - C Horreau
- Service de dermatologie, hôpital Nord, chemin des Bourrely, 13015 Marseille, France
| | - J-P Dales
- Service d'anatomopathologie, hôpital Nord, chemin des Bourrely, 13015 Marseille, France
| | - M-C Koeppel
- Service de dermatologie, hôpital Nord, chemin des Bourrely, 13015 Marseille, France
| | - P Berbis
- Service de dermatologie, hôpital Nord, chemin des Bourrely, 13015 Marseille, France
| |
Collapse
|
12
|
Troin L, Combes E, Horreau C, Brajon D, Koeppel MC, Berbis P. Léiomyomes en plaque sur brûlure chimique : première observation. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Troin L, Archier E, Gaudy C, Bruneu Y, Grob J, Richard M. Pemphigoïde bulleuse au cours du traitement par gliptines : trois cas. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
14
|
Troin L, Monestier S, Archier E, Richard MA, Gaudy-Marqueste C, Levy-Bencheton A, Grob JJ. DRESS sous vemurafenib : une bonne indication du dabrafenib ? Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|